The insider trading reports reveal that during the month of September, Sopharma sold 6 770 own shares. Total treasury stock after the transactions stood at 13 357 228 or 7.458% of issued shares. Ognyan Donev, who is an Executive Director, Chairman of the BoD and largest beneficiary owner of Sopharma, has net purchases of 6 981 shares directly and net purchases of 117 055 shares through one of his companies and a family member, accounting for 44.6% of the traded volume during the month. Our estimations show that after the transactions, Ognyan Donev controls 49.9% of the issued shares and 53.9% of the outstanding shares.